Vimta Labs (BOM:524394) ROCE % : 26.99% (As of Dec. 2024)

View and export this data going back to 1994. Start your Free Trial

What is Vimta Labs ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Vimta Labs's annualized ROCE % for the quarter that ended in Dec. 2024 was 26.99%.

Vimta Labs ROCE % Historical Data

The historical data trend for Vimta Labs's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vimta Labs ROCE % Chart

Vimta Labs Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

ROCE %

Get a 7-Day Free Trial

5.61

14.81

23.55

23.36

17.21

Vimta Labs Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
ROCE %	Get a 7-Day Free Trial															20.24	11.40	19.65	24.56	26.99

Vimta Labs ROCE % Calculation

Vimta Labs's annualized ROCE % for the fiscal year that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Mar. 2024 )		(A: Mar. 2023 )		(A: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Mar. 2024 )		(A: Mar. 2023 )		(A: Mar. 2024 )
	=	560.06	/	( ( (3623.25 - 572.77)	+	(4000.5 - 540.7) )	/ 2 )
	=	560.06	/	( (3050.48	+	3459.8)	/ 2 )
	=	560.06	/	3255.14
	=	17.21 %

Vimta Labs's ROCE % of for the quarter that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	980	/	( ( (4404.09 - 772.99)	+	(0 - 0) )	/ 1 )
	=	980	/	( ( 3631.1	+	0 )	/ 1 )
	=	980	/	3631.1
	=	26.99 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2024) EBIT data.

Vimta Labs (BOM:524394) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Vimta Labs ROCE % Related Terms

Thank you for viewing the detailed overview of Vimta Labs's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Vimta Labs Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Vimta Labs Ltd (BOM:524394) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

VIMTALABS:India

Address

Plot No.141/2 & 142, IDA, Phase-II, Cherlapally, R. R. District, Hyderabad, TG, IND, 500051

Website

https://www.vimta.com

Vimta Labs Ltd is a comprehensive contract research and testing organization, providing a wide range of services to pharmaceutical, biopharmaceutical, food, consumer goods, electronic, electrical, agrochemical, healthcare, medical device, and many other industries. Its services portfolio includes testing and contract research services in the fields of clinical research, pre-clinical research, clinical diagnostics, biopharma services, analytical testing, research and environmental studies, and Others. It has only one reportable segment namely Contract Research and Testing Services which generates the revenue.

Vimta Labs Headlines

No Headlines